Periodontal Disease and Circulatory Microbial Components
CirCo
Circulatory Microbial Components and Immune Regulators of Patients With Periodontal Disease and Rheumatoid Arthritis
1 other identifier
observational
40
0 countries
N/A
Brief Summary
The goal of this project is to study the immune activity of certain proteins present in the blood of patients with severe periodontal disease. Periodontal disease (gum disease) is the major cause of tooth loss among adults. Moderate to severe periodontal disease is reported to affect 5-15% of American adults. It begins with an infection of the tissues surrounding the teeth, and leads to a worsening inflammatory response. This study will aid in clarifying the way in which gum disease might affect certain systemic diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 16, 2010
CompletedFirst Posted
Study publicly available on registry
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedDecember 14, 2015
December 1, 2015
5.3 years
March 16, 2010
December 11, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identify microorganism components in the serum of patients with severe periodontitis
microorganism components will be analyzed in serum samples collected before teeth cleaning and again 5 minutes after teeth cleaning
1hour
Secondary Outcomes (1)
Characterize the immune regulator activity of periodontitis serum
1 hour
Study Arms (2)
Periodontitis
Patients with severe periodontal disease Intervention (Procedure/surgery): Prophylaxis; Gross debridement for diseased patients Other Names: Teeth cleaning 1 per patient at 2nd visit lasting approximately 1 hour.
Healthy patients
Patients without periodontal (gum) disease Intervention (Procedure/surgery): Prophylaxis; Gross debridement for diseased patients Other Names: Teeth cleaning
Interventions
1 per patient at 2nd visit lasting approximately 1 hour.
Eligibility Criteria
40 adult subjects comprised of two populations: 1) healthy (n=20) and 2) severe periodontal disease (n=20)
You may qualify if:
- years or older
- Healthy patients or patients with severe periodontal disease
- Patients with or without Rheumatoid Arthritis
- Patients with at least 20 permanent teeth
You may not qualify if:
- Patients will be excluded if they receive long-term use of medications known to affect periodontal status such as anti-inflammatory drugs, aspirin and ibuprofen
- Patients on immunosuppressive therapies, including glucocorticoids or cyclosporines, are excluded from participation in this study (inhalers are allowed)
- History of metabolic bone diseases such as rheumatoid arthritis or post-menopausal osteoporosis
- Pregnant women or women attempting to become pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006 Feb 24;124(4):783-801. doi: 10.1016/j.cell.2006.02.015.
PMID: 16497588BACKGROUNDForner L, Nielsen CH, Bendtzen K, Larsen T, Holmstrup P. Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling. J Clin Periodontol. 2006 Oct;33(10):724-9. doi: 10.1111/j.1600-051X.2006.00964.x. Epub 2006 Aug 10.
PMID: 16901299BACKGROUNDD'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004 Feb;83(2):156-60. doi: 10.1177/154405910408300214.
PMID: 14742655BACKGROUNDGarlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res. 2003 Apr;38(2):210-7. doi: 10.1034/j.1600-0765.2003.02012.x.
PMID: 12608917BACKGROUNDPussinen PJ, Paju S, Mantyla P, Sorsa T. Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem. 2007;14(22):2402-12. doi: 10.2174/092986707781745604.
PMID: 17896988BACKGROUNDMarchesan J, Jiao Y, Schaff RA, Hao J, Morelli T, Kinney JS, Gerow E, Sheridan R, Rodrigues V, Paster BJ, Inohara N, Giannobile WV. TLR4, NOD1 and NOD2 mediate immune recognition of putative newly identified periodontal pathogens. Mol Oral Microbiol. 2016 Jun;31(3):243-258. doi: 10.1111/omi.12116. Epub 2015 Sep 10.
PMID: 26177212RESULT
Biospecimen
Dental plaque samples evaluated for microbial DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William V Giannobile, DDS, DMedSc
University of Michigan
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 16, 2010
First Posted
July 1, 2010
Study Start
January 1, 2010
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
December 14, 2015
Record last verified: 2015-12